| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 07/13/1999 | US5922572 Polynucleotides encoding haemopoietic maturation factor |
| 07/13/1999 | US5922567 Two new human DNAJ-like proteins |
| 07/13/1999 | US5922562 Nucleic acids encoding transferrin receptors |
| 07/13/1999 | US5922323 Transferrin receptor genes and immunogenic compositions derived therefrom |
| 07/13/1999 | US5922301 Radiolabelled amino acid formulations stored in an unfrozen state |
| 07/08/1999 | WO1999033970A1 Medicinal compositions for treating or preventing influenza and novel capped oligoribonucleotides |
| 07/08/1999 | WO1999033867A2 Modified nucleic acid analogues |
| 07/07/1999 | EP0927270A1 Lyophilization of cultured human cells to preserve rna and dna |
| 07/07/1999 | EP0927188A1 Novel nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor |
| 07/07/1999 | EP0927180A1 Heterocyclic compounds and their use for isolating nucleic acids |
| 07/07/1999 | EP0927038A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent |
| 07/07/1999 | CN1222192A Antisense inhibitors of vascular endothelial growth factor (VEFG/VPF) expression |
| 07/07/1999 | CN1222158A Chimeric mutational vectors having non-natural nucleotides |
| 07/07/1999 | CN1221750A Determining high activity and spike-shape relative component in Dalaicao nuclein |
| 07/07/1999 | CN1221749A Antisensedigonucleotides for inhibiting human body tumour cell growth |
| 07/06/1999 | US5919917 Photocleavable circular oligonucleotides |
| 07/06/1999 | US5919903 Low affinity human IL-12 beta2 receptor |
| 07/06/1999 | US5919773 Antisense oligonucleotide modulation of raf gene expression |
| 07/06/1999 | US5919772 Oligonucleotide complementary to dna methyltransferase mrna. |
| 07/06/1999 | US5919692 Ubiquitous ATP-sensitive potassium-channel genes |
| 07/06/1999 | US5919690 Dna sequence encoding a polypeptide derived from a strain of aspergillus having alpha-galactosidase activity which is not inhibited by galactose; host cells transformed for efficient biosynthesis of the galactosidase |
| 07/06/1999 | US5919651 Expression of polypeptides in yeast |
| 07/06/1999 | US5919635 Using a genetic engineered receptor |
| 07/06/1999 | US5919630 Detection of nucleic acids by fluorescence quenching |
| 07/06/1999 | US5919622 Vessel with lid to hold liquid, thermostat element, disposable heating element in lid; nucleic acid preparation and amplification in a single vessel |
| 07/06/1999 | US5919619 Preferentally suppressing gene expression of target proteins by synthesizing and then hybridizing complementary oligonucleotide to subsequence of specific messenger ribonucleic acid in cell |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | CA1340627C T4 glycoprotien fragments and use of fragments of t4 in the treatment of aids |
| 07/06/1999 | CA1340625C Cloned cardionatrin cdna |
| 07/06/1999 | CA1340624C Modified vaccinia virus and methods for making and using the same |
| 07/01/1999 | WO1999032662A1 Methods and apparatus for improved luminescence assays using microparticles |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032616A2 Method for isolating short and long-chain nucleic acids |
| 07/01/1999 | WO1999032501A1 Compounds for mass spectrometry comprising nucleic acid bases and aryl ether mass markers |
| 07/01/1999 | WO1999032149A1 GENES FOR MALE ACCESSORY GLAND PROTEINS IN $i(DROSOPHILA MELANOGASTER) |
| 07/01/1999 | DE19901761A1 Oligonucleotides tagged with photoinducible redox-active unit |
| 07/01/1999 | DE19858447A1 Isolating and purifying nucleic acid |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315257A1 Method for isolating short and long-chain nucleic acids |
| 06/30/1999 | EP0925306A1 Solid phase synthesis |
| 06/30/1999 | EP0891393B1 Asymmetric benzoxanthene dyes |
| 06/30/1999 | CN1221456A 'alpha' 2 subunit of prolyl-4-hydroxylase, nucleic acid sequences encoding such subunit and methods for producing the same |
| 06/30/1999 | CN1221423A Intermediates for oligonucleotide synthesis |
| 06/30/1999 | CN1221033A Oncogene- or virus-controlled expression systems |
| 06/30/1999 | CN1220995A Total RNA extraction reagent and making method and method for extracting total RNA thereof |
| 06/29/1999 | US5917027 Nucleic acids encoding potassium-channel proteins |
| 06/29/1999 | US5917017 Diphtheria toxin vaccines bearing a mutated R domain |
| 06/29/1999 | US5916808 Hybridizing to pre-messenger rna at splice element of native intron, thus creating duplex and permitting splicing; oligonucleotide does not activate rnaase h and blocks mutant splice elements; treatment of beta-thalassemia |
| 06/29/1999 | US5916807 Inhibiting gene expression of enzyme by contacting cells with synthetic antisense agent; used as anticarcinogenic/antiproliferative/antiinflammatory agents |
| 06/29/1999 | US5916803 Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use |
| 06/29/1999 | US5916795 Thermostable xylanase |
| 06/29/1999 | US5916773 Recombinant production of fusion proteins comprising erythropoietin and GM-CSF components |
| 06/29/1999 | US5916770 Macrophage stimulating protein variant and method for producing the same |
| 06/29/1999 | US5916750 Non-nucleosidic phosphoramidites based on 1,3,5-tris(2-hydroxyethyl)cyanuric acid used to construct multiply-labeled, branched dna oligomer probes |
| 06/29/1999 | US5916539 Superparamagnetic particles, process for producing the same and their use |
| 06/29/1999 | CA2125974C Senescent cell derived inhibitors of dna synthesis |
| 06/29/1999 | CA2000878C Cdnas coding for the subunit of the high-affinity receptor for immunoglobulin e |
| 06/29/1999 | CA1340611C Recombinant alveolar surfactant protein |
| 06/24/1999 | WO1999031431A1 Method for determining a base sequence of a nucleotide strand |
| 06/24/1999 | WO1999031276A1 Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction |
| 06/24/1999 | WO1999031181A1 Rigidized trimethine cyanine dyes |
| 06/24/1999 | WO1999031119A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes |
| 06/24/1999 | WO1999031115A1 Conductive metal-containing nucleic acids |
| 06/24/1999 | WO1999019359A9 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 06/24/1999 | WO1999005155A3 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| 06/24/1999 | DE19757516A1 New oligo-nucleotide analogs with negatively charged non-nucleoside units |
| 06/23/1999 | EP0923597A1 Substituted propargylethoxyamido nucleosides |
| 06/23/1999 | EP0923596A2 Lipophilic oligonucleotide analogs |
| 06/23/1999 | EP0923595A1 Nucleic acid mediated electron transfer |
| 06/23/1999 | EP0923592A1 Methods for purifying nucleic acids |
| 06/23/1999 | EP0923591A1 Novel boronic acid-containing nucleic acids and their use as diagnostic agents |
| 06/23/1999 | EP0693078B1 Dna polymerases with enhanced thermostability and enhanced length and efficiency of primer extension |
| 06/23/1999 | EP0686043B1 Compositions and methods of application of reactive antiviral polymers |
| 06/23/1999 | CN1220606A P1, P4-dithio-P2,P3-monochloromethylene 5',5'-diadenosine P1,P4-tetraphosphate as antithrombotic agent |
| 06/23/1999 | CN1043769C L-nucleosides for treatment of hepatitis B-virus and epstein-bar virus and its use |
| 06/22/1999 | US5914396 2'-O-modified nucleosides and phosphoramidites |
| 06/22/1999 | US5914250 Gene which codes for mutant antibiotic having isoleucine substituted at 4 position of amino acid sequence |
| 06/22/1999 | US5914234 Methods of detecting growth differentiation factor-11 |
| 06/22/1999 | CA1340599C Antibiotic-producing microorganisms |
| 06/22/1999 | CA1340597C Expression vectors containing pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods |
| 06/17/1999 | WO1999029840A1 Methods of nucleic acid isolation |
| 06/17/1999 | WO1999029838A1 Fibrinogen-converting enzyme hybrids |
| 06/17/1999 | WO1999029834A1 Methods for preparation of vaccines against cancer |
| 06/17/1999 | WO1999029727A1 Cyp7 promoter-binding factors |
| 06/17/1999 | WO1999029711A1 Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics |
| 06/17/1999 | WO1999029703A2 Isolation of nucleic acids |
| 06/17/1999 | WO1999029350A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 06/17/1999 | WO1999015541A3 Use of a pentopyranosyl nucleoside for producing an electronic component, and conjugates of said pentopyranosyl nucleoside |
| 06/17/1999 | WO1999015539A3 Pentopyranosyl nucleoside, and production and use of the same |
| 06/17/1999 | WO1999005319A9 Methods and compounds for analyzing nucleic acids by mass spectrometry |
| 06/17/1999 | CA2318306A1 Isolation of nucleic acids |
| 06/17/1999 | CA2314005A1 Methods for preparation of vaccines against cancer |
| 06/17/1999 | CA2312698A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 06/17/1999 | CA2312568A1 Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics |
| 06/17/1999 | CA2312476A1 Fibrinogen-converting enzyme hybrids |
| 06/17/1999 | CA2311281A1 Cyp7 promoter-binding factors |
| 06/17/1999 | CA2310782A1 Methods of nucleic acid isolation |
| 06/16/1999 | EP0922768A2 Oncogene or virus-driven expression systems |
| 06/16/1999 | EP0922767A1 Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes |